Arineta Ltd.

Arineta Ltd. has 3 AI-enabled medical devices on the FDA list. The first decision was on October 13, 2023 and the most recent on April 15, 2025 (SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option). Its most common review panel is Radiology (3 devices).